Sorafenib in advanced hepatocellular carcinoma.

Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J, SHARP Investigators Study Group

Open source

DOI: 10.1056/nejmoa0708857
Published: 2008 Jul 24
Container: The New England journal of medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa0708857,
  title = {Sorafenib in advanced hepatocellular carcinoma.},
  author = {Llovet JM and Ricci S and Mazzaferro V and Hilgard P and Gane E and Blanc JF and de Oliveira AC and Santoro A and Raoul JL and Forner A and Schwartz M and Porta C and Zeuzem S and Bolondi L and Greten TF and Galle PR and Seitz JF and Borbath I and Häussinger D and Giannaris T and Shan M and Moscovici M and Voliotis D and Bruix J and SHARP Investigators Study Group},
  year = {2008},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa0708857},
  url = {https://doi.org/10.1056/nejmoa0708857}
}

RIS

TY  - JOUR
TI  - Sorafenib in advanced hepatocellular carcinoma.
AU  - Llovet JM
AU  - Ricci S
AU  - Mazzaferro V
AU  - Hilgard P
AU  - Gane E
AU  - Blanc JF
AU  - de Oliveira AC
AU  - Santoro A
AU  - Raoul JL
AU  - Forner A
AU  - Schwartz M
AU  - Porta C
AU  - Zeuzem S
AU  - Bolondi L
AU  - Greten TF
AU  - Galle PR
AU  - Seitz JF
AU  - Borbath I
AU  - Häussinger D
AU  - Giannaris T
AU  - Shan M
AU  - Moscovici M
AU  - Voliotis D
AU  - Bruix J
AU  - SHARP Investigators Study Group
PY  - 2008
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa0708857
UR  - https://doi.org/10.1056/nejmoa0708857
ER  -

APA

JM, L., S, R., V, M., P, H., E, G., JF, B., AC, D. O., A, S., JL, R., A, F., M, S., C, P., S, Z., L, B., TF, G., PR, G., JF, S., I, B., D, H., T, G., M, S., M, M., D, V., J, B., & Group, S. I. S. (2008). Sorafenib in advanced hepatocellular carcinoma.. The New England journal of medicine. https://doi.org/10.1056/nejmoa0708857

Source records

pubmed · retrieved 2026-09-25T01:01:15.443Z